Paper
Organic & Biomolecular Chemistry
1
3-(1-Cyclohexyl-2-nitroethyl)-1H-indole (3ha)25
134–137 °C. H NMR (400 MHz, CD2Cl2) δ = 8.40 (s, 1H), 7.60
(s, 1H), 7.43–7.28 (m, 7H), 7.17 (d, J = 1.8 Hz, 1H), 5.22–5.05
(m, 2H), 5.00 (dd, J = 12.2, 8.0 Hz, 1H). 13C NMR (101 MHz,
CD2Cl2) δ = 139.1, 135.1, 128.9, 127.9, 127.7, 127.6, 125.4,
122.9, 121.3, 114.0, 113.0, 112.9, 79.5, 41.3. ESI-MS: m/z [M +
H]+ calcd for C16H14BrN2O2: 345.03; found: 345.06.
General procedure was followed using 1h (0.2 mmol, 31.0 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3ha (46.6 mg, 90%) as a yellow wax. 1H NMR
(400 MHz, CD2Cl2) δ = 8.27 (s, 1H), 7.66 (d, J = 8.1 Hz, 1H),
7.42 (d, J = 8.1 Hz, 1H), 7.29–7.20 (m, 1H), 7.16 (td, J = 7.6, 7.1,
1.0 Hz, 1H), 7.06 (d, J = 2.4 Hz, 1H), 4.89 (dd, J = 11.9, 5.9 Hz,
1H), 4.78 (dd, J = 11.9, 10.0 Hz, 1H), 3.70 (dt, J = 9.9, 6.6 Hz,
1H), 1.98–1.75 (m, 3H), 1.75–1.61 (m, 3H), 1.39–0.97 (m, 5H).
13C NMR (101 MHz, CD2Cl2) δ = 136.3, 126.9, 122.4, 122.1,
119.5, 119.0, 113.2, 111.4, 78.7, 41.9, 40.6, 31.2, 30.5, 26.3.
ESI-MS: m/z [M + H]+ calcd for C16H21N2O2: 273.16; found:
273.13.
6-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (3bf)28
General procedure was followed using 1b (0.2 mmol, 29.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3bf (46.4 mg, 77%) as a yellow wax. 1H NMR (400 MHz,
CD2Cl2) δ = 8.33 (s, 1H), 7.44–7.41 (m, 1H), 7.40–7.35 (m, 5H),
7.35–7.29 (m, 1H), 7.15 (d, J = 1.8 Hz, 1H), 7.06 (dd, J = 8.6, 1.8
Hz, 1H), 5.19 (t, J = 7.9 Hz, 1H), 5.11 (dd, J = 12.3, 7.8 Hz, 1H),
5.00 (dd, J = 12.3, 8.1 Hz, 1H). 13C NMR (101 MHz, CD2Cl2) δ =
139.2, 136.8, 128.9, 128.4, 127.7, 127.6, 124.81, 122.3, 120.4,
119.8, 114.6, 111.3, 79.5, 41.4. ESI-MS: m/z [M + H]+ calcd for
C16H14ClN2O2: 301.07; found: 301.03.
3-(2-Nitro-1-phenylethyl)-1H-indol-5-ol (3bb)27
General procedure was followed 1b (0.2 mmol, 29.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3bb (53.6 mg, 95%) as a yellow solid. M. p. = 122–126 °C.
1H NMR (400 MHz, CD2Cl2) δ = 8.20 (s, 1H), 7.40–7.35 (m, 4H),
7.35–7.29 (m, 1H), 7.27 (d, J = 8.7 Hz, 1H), 7.11 (d, J = 2.3 Hz,
1H), 6.84 (d, J = 2.3 Hz, 1H), 6.78 (dd, J = 8.7, 2.3 Hz, 1H),
5.17–5.05 (m, 2H), 5.04–4.94 (m, 1H), 4.82 (s, 1H). 13C NMR
(101 MHz, CD2Cl2) δ = 149.7, 139.5, 131.7, 128.9, 127.7, 127.5,
126.8, 122.6, 113.6, 112.4, 112.1, 103.1, 79.5, 41.5. ESI-MS: m/z
[M + H]+ calcd for C16H15N2O3: 283.11; found: 283.07.
3-(1-(4-Methoxyphenyl)-2-nitroethyl)-1-methyl-1H-indole (3ag)29
General procedure was followed using 1a (0.2 mmol, 35.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3ag (56.2 mg, 91%) as a whitish oil. 1H NMR
(400 MHz, CD2Cl2) δ = 7.47 (d, J = 7.9 Hz, 1H), 7.35 (d, J = 8.2
Hz, 1H), 7.32–7.19 (m, 3H), 7.09 (t, J = 7.4 Hz, 1H), 6.96 (s, 1H),
6.90 (d, J = 7.2 Hz, 2H), 5.20–5.06 (m, 2H), 5.02–4.90 (m, 1H),
3.81 (s, 3H), 3.78 (s, 3H). 13C NMR (101 MHz, CD2Cl2) δ =
159.0, 137.3, 131.6, 128.8, 126.5, 126.1, 122.1, 119.2, 118.8,
114.1, 113.0, 109.5, 79.8, 55.2, 40.8, 32.7. ESI-MS: m/z [M + H]+
calcd for C18H19N2O2: 311.14; found: 311.17.
5-Methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (3bc)25
General procedure was followed using 1b (0.2 mmol, 29.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3bc (55.2 mg, 93%) as a yellow solid. M. p. =
137–140 °C. 1H NMR (400 MHz, CD2Cl2) δ = 8.22 (s, 1H),
7.44–7.36 (m, 4H), 7.35–7.26 (m, 2H), 7.09 (d, J = 2.6 Hz, 1H),
6.89 (s, 1H), 6.87 (d, J = 2.4 Hz, 1H), 5.21–5.13 (m, 2H), 5.02
(dd, J = 12.0, 8.3 Hz, 1H), 3.80 (s, 3H). 13C NMR (101 MHz,
CD2Cl2) δ = 154.2, 139.5, 131.6, 128.9, 127.8, 127.5, 126.5,
122.3, 113.9, 112.5, 112.1, 100.6, 79.5, 55.7, 41.5. ESI-MS: m/z
[M + H]+ calcd for C17H17N2O3: 297.12; found: 297.09.
1-Benzyl-3-(1-(4-methoxyphenyl)-2-nitroethyl)-1H-indole (3ah)29
General procedure was followed using 1a (0.2 mmol, 35.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3ah (71.6 mg, 93%) as a whitish oil. 1H NMR
(400 MHz, CD2Cl2) δ = 7.49 (d, J = 7.9 Hz, 1H), 7.39–7.29 (m,
6H), 7.21 (d, J = 7.7 Hz, 1H), 7.15 (d, J = 7.2 Hz, 2H), 7.10 (d, J =
7.8 Hz, 2H), 6.92 (d, J = 7.3 Hz, 2H), 5.35 (s, 2H), 5.19 (t, J = 7.8
Hz, 1H), 5.16–5.07 (m, 1H), 5.02–4.93 (m, 1H), 3.82 (s, 3H). 13
C
5-Fluoro-3-(2-nitro-1-phenylethyl)-1H-indole (3bd)27
NMR (101 MHz, CD2Cl2) δ = 159.0, 137.6, 136.9, 131.5, 128.8,
128.7, 127.6, 126.9, 126.7, 125.6, 122.3, 119.5, 119.1, 114.2,
113.8, 110.0, 79.9, 55.2, 50.1, 40.9. ESI-MS: m/z [M + H]+ calcd
for C24H23N2O3: 387.17; found: 387.19.
General procedure was followed using 1b (0.2 mmol, 29.8 mg).
Purification by column chromatography (n-hex/EtOAc 95 : 5)
yielded 3bd (50.7 mg, 89%) as a yellow wax. 1H NMR
(400 MHz, CD2Cl2) δ = 8.35 (s, 1H), 7.41–7.30 (m, 6H), 7.21 (d,
J = 2.1 Hz, 1H), 7.10 (d, J = 9.7 Hz, 1H), 6.98 (td, J = 9.1, 2.1 Hz,
1H), 5.20–5.07 (m, 2H), 5.01 (dd, J = 11.1, 7.0 Hz, 1H). 13C
1
Conflicts of interest
NMR (101 MHz, CD2Cl2) δ = 157.7 (d, JC–F = 234 Hz), 139.2,
5
133.0, 128.9, 127.7, 127.6, 126.5 (d, JC–F = 10 Hz), 123.3, 114.4
There are no conflicts to declare.
6
4
2
(d, JC–F = 5 Hz), 112.2 (d, JC–F = 11 Hz) 110.9 (d, JC–F = 26
Hz), 103.7 (d, JC–F = 24 Hz), 79.5, 41.4. ESI-MS: m/z [M + H]+
3
calcd for C16H14FN2O2: 285.10; found: 285.11.
Acknowledgements
5-Bromo-3-(2-nitro-1-phenylethyl)-1H-indole (3be)25
The authors thank Centro Interdipartimentale di Misure of the
General procedure was followed using 1b (0.2 mmol, 29.8 mg). University of Parma for NMR measurement and B.Sc. student
Purification by column chromatography (n-hex/EtOAc 95 : 5) Nicholas Grassi for experimental support. Chiesi Farmaceutici
yielded 3be (58.6 mg, 85%) as a white solid. M. p. = SpA is acknowledged for the support for the D8 Venture. This
1552 | Org. Biomol. Chem., 2021, 19, 1546–1554
This journal is © The Royal Society of Chemistry 2021